PMC:7242013 / 6559-7785 JSON TXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T26","span":{"begin":644,"end":649},"obj":"Body_part"}],"attributes":[{"id":"A26","pred":"fma_id","subj":"T26","obj":"http://purl.org/sig/ont/fma/fma67498"}],"text":"Manage pretransplant and posttransplant patients Screen donors and recipient for COVID‐19\nDo not postpone transplants (an essential medical service, CMS Tier 3b)\nNotify patients of possible extended waiting times on transplant list\nHave low threshold for admitting patients on transplant waiting list diagnosed with COVID‐19\nFor posttransplant patients with moderate COVID‐19, consider reduction of immunosuppression therapy as appropriate\nDo not reduce immunosuppressive therapy in patients with mild COVID‐19 disease Test donors and recipient for COVID‐19\nLimit transplant listing to emergency and urgent cases\nLook for SARS‐COV‐2 prior to organ procurement; defer donors with evidence of infection\nConsider specific COVD‐19 consent for patients on transplant waiting list\nFor posttransplant patient with moderate COVID‐19, consider reduction of immunosuppression therapy as appropriate\nDo not reduce immunosuppressive therapy in patients with mild COVID‐19 disease Maintain care per guidelines\nLimit transplantation listings to patients with poor short‐term prognosis\nVaccinate against pneumonia and flu\nAvoid reductions in immunosuppressive therapy\nDo not reduce immunosuppressive therapy in patients with mild COVID‐19"}

LitCovid-PubTator

LitCovid-PD-UBERON

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T24","span":{"begin":644,"end":649},"obj":"Body_part"}],"attributes":[{"id":"A24","pred":"uberon_id","subj":"T24","obj":"http://purl.obolibrary.org/obo/UBERON_0000062"}],"text":"Manage pretransplant and posttransplant patients Screen donors and recipient for COVID‐19\nDo not postpone transplants (an essential medical service, CMS Tier 3b)\nNotify patients of possible extended waiting times on transplant list\nHave low threshold for admitting patients on transplant waiting list diagnosed with COVID‐19\nFor posttransplant patients with moderate COVID‐19, consider reduction of immunosuppression therapy as appropriate\nDo not reduce immunosuppressive therapy in patients with mild COVID‐19 disease Test donors and recipient for COVID‐19\nLimit transplant listing to emergency and urgent cases\nLook for SARS‐COV‐2 prior to organ procurement; defer donors with evidence of infection\nConsider specific COVD‐19 consent for patients on transplant waiting list\nFor posttransplant patient with moderate COVID‐19, consider reduction of immunosuppression therapy as appropriate\nDo not reduce immunosuppressive therapy in patients with mild COVID‐19 disease Maintain care per guidelines\nLimit transplantation listings to patients with poor short‐term prognosis\nVaccinate against pneumonia and flu\nAvoid reductions in immunosuppressive therapy\nDo not reduce immunosuppressive therapy in patients with mild COVID‐19"}

LitCovid-PD-MONDO

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T94","span":{"begin":82,"end":90},"obj":"Disease"},{"id":"T95","span":{"begin":150,"end":153},"obj":"Disease"},{"id":"T96","span":{"begin":317,"end":325},"obj":"Disease"},{"id":"T97","span":{"begin":368,"end":376},"obj":"Disease"},{"id":"T98","span":{"begin":503,"end":511},"obj":"Disease"},{"id":"T99","span":{"begin":551,"end":559},"obj":"Disease"},{"id":"T100","span":{"begin":624,"end":628},"obj":"Disease"},{"id":"T101","span":{"begin":693,"end":702},"obj":"Disease"},{"id":"T102","span":{"begin":818,"end":826},"obj":"Disease"},{"id":"T103","span":{"begin":953,"end":961},"obj":"Disease"},{"id":"T104","span":{"begin":1092,"end":1101},"obj":"Disease"},{"id":"T105","span":{"begin":1106,"end":1109},"obj":"Disease"},{"id":"T106","span":{"begin":1218,"end":1226},"obj":"Disease"}],"attributes":[{"id":"A94","pred":"mondo_id","subj":"T94","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A95","pred":"mondo_id","subj":"T95","obj":"http://purl.obolibrary.org/obo/MONDO_0018940"},{"id":"A96","pred":"mondo_id","subj":"T96","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A97","pred":"mondo_id","subj":"T97","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A98","pred":"mondo_id","subj":"T98","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A99","pred":"mondo_id","subj":"T99","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A100","pred":"mondo_id","subj":"T100","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A101","pred":"mondo_id","subj":"T101","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A102","pred":"mondo_id","subj":"T102","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A103","pred":"mondo_id","subj":"T103","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A104","pred":"mondo_id","subj":"T104","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"},{"id":"A105","pred":"mondo_id","subj":"T105","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"},{"id":"A106","pred":"mondo_id","subj":"T106","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Manage pretransplant and posttransplant patients Screen donors and recipient for COVID‐19\nDo not postpone transplants (an essential medical service, CMS Tier 3b)\nNotify patients of possible extended waiting times on transplant list\nHave low threshold for admitting patients on transplant waiting list diagnosed with COVID‐19\nFor posttransplant patients with moderate COVID‐19, consider reduction of immunosuppression therapy as appropriate\nDo not reduce immunosuppressive therapy in patients with mild COVID‐19 disease Test donors and recipient for COVID‐19\nLimit transplant listing to emergency and urgent cases\nLook for SARS‐COV‐2 prior to organ procurement; defer donors with evidence of infection\nConsider specific COVD‐19 consent for patients on transplant waiting list\nFor posttransplant patient with moderate COVID‐19, consider reduction of immunosuppression therapy as appropriate\nDo not reduce immunosuppressive therapy in patients with mild COVID‐19 disease Maintain care per guidelines\nLimit transplantation listings to patients with poor short‐term prognosis\nVaccinate against pneumonia and flu\nAvoid reductions in immunosuppressive therapy\nDo not reduce immunosuppressive therapy in patients with mild COVID‐19"}

LitCovid-PD-CLO

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T61","span":{"begin":521,"end":525},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T62","span":{"begin":644,"end":649},"obj":"http://purl.obolibrary.org/obo/UBERON_0003103"}],"text":"Manage pretransplant and posttransplant patients Screen donors and recipient for COVID‐19\nDo not postpone transplants (an essential medical service, CMS Tier 3b)\nNotify patients of possible extended waiting times on transplant list\nHave low threshold for admitting patients on transplant waiting list diagnosed with COVID‐19\nFor posttransplant patients with moderate COVID‐19, consider reduction of immunosuppression therapy as appropriate\nDo not reduce immunosuppressive therapy in patients with mild COVID‐19 disease Test donors and recipient for COVID‐19\nLimit transplant listing to emergency and urgent cases\nLook for SARS‐COV‐2 prior to organ procurement; defer donors with evidence of infection\nConsider specific COVD‐19 consent for patients on transplant waiting list\nFor posttransplant patient with moderate COVID‐19, consider reduction of immunosuppression therapy as appropriate\nDo not reduce immunosuppressive therapy in patients with mild COVID‐19 disease Maintain care per guidelines\nLimit transplantation listings to patients with poor short‐term prognosis\nVaccinate against pneumonia and flu\nAvoid reductions in immunosuppressive therapy\nDo not reduce immunosuppressive therapy in patients with mild COVID‐19"}

LitCovid-PD-CHEBI

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T28","span":{"begin":0,"end":6},"obj":"Chemical"}],"attributes":[{"id":"A28","pred":"chebi_id","subj":"T28","obj":"http://purl.obolibrary.org/obo/CHEBI_81767"}],"text":"Manage pretransplant and posttransplant patients Screen donors and recipient for COVID‐19\nDo not postpone transplants (an essential medical service, CMS Tier 3b)\nNotify patients of possible extended waiting times on transplant list\nHave low threshold for admitting patients on transplant waiting list diagnosed with COVID‐19\nFor posttransplant patients with moderate COVID‐19, consider reduction of immunosuppression therapy as appropriate\nDo not reduce immunosuppressive therapy in patients with mild COVID‐19 disease Test donors and recipient for COVID‐19\nLimit transplant listing to emergency and urgent cases\nLook for SARS‐COV‐2 prior to organ procurement; defer donors with evidence of infection\nConsider specific COVD‐19 consent for patients on transplant waiting list\nFor posttransplant patient with moderate COVID‐19, consider reduction of immunosuppression therapy as appropriate\nDo not reduce immunosuppressive therapy in patients with mild COVID‐19 disease Maintain care per guidelines\nLimit transplantation listings to patients with poor short‐term prognosis\nVaccinate against pneumonia and flu\nAvoid reductions in immunosuppressive therapy\nDo not reduce immunosuppressive therapy in patients with mild COVID‐19"}

LitCovid-sentences

{"project":"LitCovid-sentences","denotations":[{"id":"T86","span":{"begin":0,"end":90},"obj":"Sentence"},{"id":"T87","span":{"begin":91,"end":162},"obj":"Sentence"},{"id":"T88","span":{"begin":163,"end":232},"obj":"Sentence"},{"id":"T89","span":{"begin":233,"end":325},"obj":"Sentence"},{"id":"T90","span":{"begin":326,"end":440},"obj":"Sentence"},{"id":"T91","span":{"begin":441,"end":559},"obj":"Sentence"},{"id":"T92","span":{"begin":560,"end":614},"obj":"Sentence"},{"id":"T93","span":{"begin":615,"end":702},"obj":"Sentence"},{"id":"T94","span":{"begin":703,"end":776},"obj":"Sentence"},{"id":"T95","span":{"begin":777,"end":890},"obj":"Sentence"},{"id":"T96","span":{"begin":891,"end":999},"obj":"Sentence"},{"id":"T97","span":{"begin":1000,"end":1073},"obj":"Sentence"},{"id":"T98","span":{"begin":1074,"end":1109},"obj":"Sentence"},{"id":"T99","span":{"begin":1110,"end":1155},"obj":"Sentence"},{"id":"T100","span":{"begin":1156,"end":1226},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Manage pretransplant and posttransplant patients Screen donors and recipient for COVID‐19\nDo not postpone transplants (an essential medical service, CMS Tier 3b)\nNotify patients of possible extended waiting times on transplant list\nHave low threshold for admitting patients on transplant waiting list diagnosed with COVID‐19\nFor posttransplant patients with moderate COVID‐19, consider reduction of immunosuppression therapy as appropriate\nDo not reduce immunosuppressive therapy in patients with mild COVID‐19 disease Test donors and recipient for COVID‐19\nLimit transplant listing to emergency and urgent cases\nLook for SARS‐COV‐2 prior to organ procurement; defer donors with evidence of infection\nConsider specific COVD‐19 consent for patients on transplant waiting list\nFor posttransplant patient with moderate COVID‐19, consider reduction of immunosuppression therapy as appropriate\nDo not reduce immunosuppressive therapy in patients with mild COVID‐19 disease Maintain care per guidelines\nLimit transplantation listings to patients with poor short‐term prognosis\nVaccinate against pneumonia and flu\nAvoid reductions in immunosuppressive therapy\nDo not reduce immunosuppressive therapy in patients with mild COVID‐19"}

LitCovid-PD-HP

{"project":"LitCovid-PD-HP","denotations":[{"id":"T20","span":{"begin":1092,"end":1101},"obj":"Phenotype"}],"attributes":[{"id":"A20","pred":"hp_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/HP_0002090"}],"text":"Manage pretransplant and posttransplant patients Screen donors and recipient for COVID‐19\nDo not postpone transplants (an essential medical service, CMS Tier 3b)\nNotify patients of possible extended waiting times on transplant list\nHave low threshold for admitting patients on transplant waiting list diagnosed with COVID‐19\nFor posttransplant patients with moderate COVID‐19, consider reduction of immunosuppression therapy as appropriate\nDo not reduce immunosuppressive therapy in patients with mild COVID‐19 disease Test donors and recipient for COVID‐19\nLimit transplant listing to emergency and urgent cases\nLook for SARS‐COV‐2 prior to organ procurement; defer donors with evidence of infection\nConsider specific COVD‐19 consent for patients on transplant waiting list\nFor posttransplant patient with moderate COVID‐19, consider reduction of immunosuppression therapy as appropriate\nDo not reduce immunosuppressive therapy in patients with mild COVID‐19 disease Maintain care per guidelines\nLimit transplantation listings to patients with poor short‐term prognosis\nVaccinate against pneumonia and flu\nAvoid reductions in immunosuppressive therapy\nDo not reduce immunosuppressive therapy in patients with mild COVID‐19"}

PMC:7242013 / 6559-7785 JSONTXT

Annnotations TAB JSON ListView MergeView

PMC:7242013 / 6559-7785 JSON TXT